207- Lee JH, Slifman NR, Gershon SK, Edwards ET, Schwieterman WD, Siegel JN, et al. Life-
threatening histoplasmosis complicating immunotherapy with tumor necrosis factor α antag-
onists infliximab and etanercept. Arthritis Rheum. 2002;46:2565–70. - Vergidis P, Avery RK, Wheat LJ, Dotson JL, Assi MA, Antoun SA, et al. Histoplasmosis
complicating tumor necrosis factor-α blocker therapy: a retrospective analysis of 98 cases.
Clin Infect Dis. 2015;61(3):409–17. - Velayos FS, Sandborn WJ. Pneumocystis carinii pneumonia during maintenance anti-tumor
necrosis factor-alpha therapy with infliximab for Crohn’s disease. Inflamm Bowel Dis.
2004;10:657–60. - Seddik M, Meliez H, Seguy D, Viget N, Cortot A, Colombel JF. Pneumocystis jiroveci (cari-
nii) pneumonia following initiation of infliximab and azathioprine therapy in a patient with
Crohn’s disease. Inflamm Bowel Dis. 2004;10:436–7. - Kaur N, Mahl TC. Pneumocystis carinii pneumonia with oral candidiasis after infliximab
therapy for Crohn’s disease. Dig Dis Sci. 2004;49:1458–60. - Kaur N, Mahl TC. Pneumocystis jiroveci (carinii) pneumonia after infliximab therapy: a
review of 84 cases. Dig Dis Sci. 2007;52(6):1481–4. - Okafor PN, Nunes DP, Farraye FA. Pneumocystis jiroveci pneumonia in inflammatory bowel
disease: when should prophylaxis be considered? Inflamm Bowel Dis. 2013;19:1764–71. - Tubach F, Ravaud P, Salmon-Ceron D, Petitpain N, Brocq O, Grados F, et al. Emergence of
legionella pneumophila pneumonia in patients receiving tumor necrosis factor-alpha antago-
nists. Clin Infect Dis. 2006;43:e95–100. - Epping G, van der Valk PD, Hendrix R. Legionella pneumophila pneumonia in a pregnant
woman treated with anti-TNF-alpha antibodies for Crohn’s disease: a case report. J Crohns
Colitis. 2010;4:687–9. - Beigel F, Matthias J, Filik L, Bader L, Lück C, Göke B, et al. Severe legionella pneumophila
pneumonia following infliximab therapy in a patient with Crohn’s disease. Inflamm Bowel
Dis. 2009;15:1240–4. - Jinno S, Pulido S, Pien BC. First reported United States case of legionella pneumophila sero-
group 1 pneumonia in a patient receiving anti-tumor necrosis factor-alpha therapy. Hawaii
Med J. 2009;68:109–12. - Kohn A, Daperno M, Armuzzi A, Cappello M, Biancone L, Orlando A, et al. Infliximab
in severe ulcerative colitis: short-term results of different infusion regimens and long-term
follow-up. Aliment Pharmacol Ther. 2007;26:747–56. - Edelstein P, Lück C. Legionella. In: Jorgensen J, Pfaller M, Carroll K, Funke G, Landry M,
Richter S, et al., editors. Manual of clinical microbiology. 11th ed. Washington, DC: ASM
Press; 2015. p. 887–904. - Slifman NR, Gershon SK, Lee J-H, Edwards ET, Braun MM. Listeria monocytogenes
Infection as a complication of treatment with tumor necrosis factor alpha-neutralizing agents.
Arthritis Rheum. 2003;48:319–24. - Williams G, Khan AA, Schweiger F. Listeria meningitis complicating infliximab treatment
for Crohn’s disease. Can J Infect Dis Med Microbiol. 2005;16:289–92. - Triantafillidis J, Sklavaina M, Panteris V, Georgopoulos F, Merikas E. Listeria meningitis in
an immunocompromised patient with ulcerative colitis: report of a case and review of the
literature. Ann Gastroenterol. 2010;23(3):205–8. - Weinberg E. Listeria monocytogenes in a patient with collagenous and ulcerative colitis. Am
J Gastroenterol. 2012;107:S458. - Abreu C, Magro F, Vilas-Boas F, Lopes S, Macedo G, Sarmento A. Listeria infection in
patients on anti-TNF treatment: report of two cases and review of the literature. J Crohns
Colitis. 2013;7:175–82. - Rana F, Shaikh MM, Bowles J. Listeria meningitis and resultant symptomatic hydrocephalus com-
plicating infliximab treatment for ulcerative colitis. JRSM Open. 2014;5:2054270414522223. - Parihar V, Maguire S, Shahin A, Ahmed Z, O’Sullivan M, Kennedy M, et al. Listeria menin-
gitis complicating a patient with ulcerative colitis on concomitant infliximab and hydrocorti-
sone. Ir J Med Sci. 2016;185:965–7.
12 Infectious Complications of Biologics